Summary
This prediction ended on 03.12.10 with a price of €2.70. The price for Evotec SE massively increased, which is bad news for the SELL prediction by Sievi. Sievi has 50% into this predictionEvotec is a German-based biotech company that provides drug discovery and development solutions to pharmaceutical and biotechnology companies. The company operates in the fields of neuroscience, immunology, oncology, and infectious diseases, and its services include hit identification, target validation, and preclinical and clinical development. Evotec has partnerships with major pharmaceutical companies and has developed its own pipeline of drugs, with a focus on developing treatments for conditions such as Alzheimer's disease and diabetes. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of approximately €5.5 billion.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Evotec SE | -6.401% | -6.401% | -65.782% | -84.815% |
iShares Core DAX® | -1.958% | 4.037% | 23.702% | 22.534% |
iShares Nasdaq 100 | 0.272% | 8.670% | 28.181% | 41.859% |
iShares Nikkei 225® | 0.377% | 7.232% | 21.118% | 9.739% |
iShares S&P 500 | 0.370% | 6.511% | 29.221% | 41.850% |
Comments by Sievi for this prediction
In the thread Evotec AG diskutieren
Korrektur wahrscheinlich.
Der Wert steht immer noch rund 250% über den Tiefstständen vom Februar 2009. Im Zuge der nächsten Abwärtsbewegung an den Märkten ist das Korrekturpotenzial entsprechend hoch.